ROZUSAF F 5 TABLET

Product Description

ROZUSAF F 5 TABLET | Rosuvastatin 5mg + Fenofibrate 67mg | Lipid-Lowering Combination

ROZUSAF F 5 TABLET is a powerful pharmaceutical formulation combining Rosuvastatin 5mg and Fenofibrate 67mg designed to effectively manage dyslipidemia and mixed hyperlipidemia. This synergistic combination helps in reducing LDL cholesterol, triglycerides, and increasing HDL cholesterol levels, supporting cardiovascular health and reducing the risk of heart-related complications.

Key Benefits:

• Dual-action formula targeting cholesterol and triglyceride control

• Enhances lipid profile management in patients with mixed dyslipidemia

• Supports prevention of atherosclerosis and related cardiovascular diseases

• Ideal for patients requiring combined statin and fibrate therapy

Usage:
Recommended under medical supervision for patients with elevated cholesterol and triglyceride levels who require combination therapy to achieve optimal lipid control.

Why Choose ROZUSAF F 5 TABLET?
Manufactured under stringent quality standards, ROZUSAF F 5 ensures high efficacy and safety. Perfect for bulk procurement by medical distributors, pharmaceutical retailers, hospitals, and healthcare providers aiming to offer effective lipid management solutions.